TABLE 3.
PCR Ct Values Days Post Symptom Onset
| Pt | Test 2 | Test 3 | Test 4 | Add. Tests | Total Tests | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Result | Days | Ct 1 | Ct 2 | Result | Ct 1 | Ct 2 | Result | Ct 1 | Ct 2 | |||
| 1 | − | 38 | − | − | + | 32.5 | 32.5 | − | − | − | 3 | 7 |
| 2 | + | 7 | 21.8 | 20.5 | + | 31.4 | 31.1 | − | − | − | 1 | 5 |
| 3 | − | 27 | − | − | − | 2 | ||||||
| 4 | + | 20 | 37.4 | 40.5 | − | − | − | + | 32.3 | 33.3 | 2 | 6 |
| 5 | + | 37 | 25.0 | 36.8 | − | 2 | ||||||
| 6 | + | 40 | 27.3 | 27.5 | − | − | − | − | 3 | |||
| 7 | + | 46 | 23.9 | 24.4 | + | 32.4 | 32.8 | + | 31.8 | 32.7 | 3 | 7 |
| 8 | + | 15 | − | 2 | ||||||||
| 9 | + | 17 | − | 36.1 | − | − | − | − | 3 | |||
| 10 | + | 20 | 29.9 | 30.0 | + | 29.2 | 29.9 | − | 3 | |||
| 11 | + | 21 | 33.5 | 34.5 | − | − | − | − | − | − | − | 4 |
| 12 | − | 25 | − | − | + | 0.0 | 39.8 | + | 0 | 40.4 | − | 4 |
| 13 | + | 13 | 28.0 | 30.5 | − | − | − | + | 29.2 | 29.7 | 1 | 5 |
| 14 | + | 18 | 27.3 | 29.7 | − | 2 | ||||||
| 15 | + | 10 | − | − | − | 2 | ||||||
| 16 | + | 25 | 36.1 | 35.8 | − | − | − | − | − | − | − | 4 |
| 17 | − | 20 | − | − | + | 34.2 | 34.4 | − | − | − | − | 4 |
| 18 | − | 26 | − | − | − | − | − | − | 3 | |||
| 19 | + | 15 | 26.1 | 26.4 | + | 26.1 | 26.2 | − | − | − | 5 | 9 |
| 20 | − | 10 | − | − | + | 34.7 | 34.4 | − | − | − | 2 | 6 |
| 21 | + | 17 | 32.3 | 32.6 | + | 35.5 | 34.6 | − | − | − | 3 | 7 |
| 22 | + | 4 | 21.6 | 23.9 | + | 37.8 | − | − | − | − | 4 | 8 |
| 23 | − | 6 | − | − | − | − | − | − | − | − | − | 4 |
| 24 | − | 18 | − | − | − | 2 | ||||||
| 25 | + | 29 | 34.7 | 35.7 | − | − | − | − | − | − | − | 4 |
| 26 | + | 12 | 28.1 | 28.1 | − | 2 | ||||||
| 27 | + | 11 | 33.4 | 34.2 | − | − | − | − | − | − | − | 4 |
| 28 | + | 11 | 19.6 | N/A | − | 2 | ||||||
| 29 | + | 7 | − | 2 | ||||||||
| 30 | + | 6 | 29.3 | N/A | − | − | N/A | − | − | N/A | 1 | 5 |
| 31 | + | 4 | 14.5 | N/A | + | 16.0 | N/A | + | 16.2 | N/A | 7 | 11 |
| 32 | + | 5 | 23.3 | N/A | + | 22.6 | 22.4 | + | 28.5 | 28.3 | 1 | 5 |
| 33 | + | 12 | 32.8 | 32.7 | − | − | N/A | − | − | N/A | − | 4 |
| 34 | + | 3 | 14.4 | N/A | − | 2 | ||||||
Days denotes days after symptom onset. Ct 1 is the Ct value for genome target 1, and Ct 2 is Ct value for target 2. Bold data indicate patients declared ready for discharge based on symptom-based strategy and Ct values lower than 30.
Pt indicates patient; NA, not applicable (QuantStudio 1 target).